Treatment type: genomics
-
State-of-the art genomic sequencer accelerates inflammation research
Hudson Institute of Medical Research is progressing its genomic and inflammation research with the acquisition of an Illumina NextSeq 2000, a new sequencing system that provides unprecedented genomic capacity to study inflammatory diseases and microbial diversity.… Read more